Subscribe Become an Author Add Company Sign Up Log In

Enamine and Chemspace collaborate with Blue Dolphin Lead Discovery to expand Drug Discovery Services

   by Enamine, Contributor    69    Comments 0

Disclaimer: All opinions expressed by Contributors are their own and do not represent those of their employers, or BiopharmaTrend.com.
Contributors are fully responsible for assuring they own any required copyright for any content they submit to BiopharmaTrend.com. This website and its owners shall not be liable for neither information and content submitted for publication by Contributors, nor its accuracy.

Today Enamine, a leading provider of small molecules and drug discovery services, Chemspace, an online catalog with the largest offer of small molecules to search and buy, and Blue Dolphin Lead Discovery, a research organization focused on a fee-for-service virtual screening, announced the launch of the collaboration to support drug discovery projects.

The collaboration will include participation in the joint projects related to virtual screening and lead optimization. These projects require high expertise in molecular docking, ligand-based design, availability of well-curated catalog, and strong chemistry and biology support.

Blue Dolphin Lead Discovery will contribute with its expertise in virtual screening gained from a number of successfully conducted projects. Chemspace will provide its extensive and thoroughly curated catalog of off-the-shelf and make-on-demand compounds, project management, and logistics.
Enamine's synthetic capabilities will allow the company to deliver the necessary molecules employing its REAL approach to access billions of make-on-demand analogs as well as testing their binding and ADME/T properties.

“We look forward to developing productive research collaborations.” — comments Iryna Yavnyuk, Director of Business Development of Enamine. She continues: “This is a great opportunity for Enamine to expand a portfolio of our Drug Discovery services”.

“This collaboration will undoubtedly be useful for our customers to help them leverage the Chemspace catalog in their projects”, Dr. Yurii Moroz, CEO of Chemspace adds.

“Having a partner we trust that supports delivery of compounds close to 100% is very important for projects based on virtual screening. Both companies, Enamine and Chemspace, have this capability.” says Dr. John Irwin, co-founder of Blue Dolphin Lead Discovery.

About Enamine Ltd. http://www.enamine.net
Established in Kyiv, Ukraine in 1991, Enamine is a chemical company producing building blocks and screening libraries of world reputation. The major asset of the company is the world's largest collection of building blocks: 200,000 in stock with 2,000 additions synthesized each month. These research functionalized compounds provide a significant competitive advantage to the company in supplying custom compound libraries particularly in the frame of medicinal chemistry collaborations or compound collection enhancement programs.

About Chemspace LLC. https://chem-space.com/
Established in Kyiv, Ukraine in 2016. Chemspace operates worldwide offering the largest catalog of small molecules. Users can perform a convenient and fast search in 13 billion building blocks, fragments, and screening compounds.

About Blue Dolphin Lead Discovery LLC. http://bluedolphindiscovery.com/
Blue Dolphin Lead Discovery is a fee-for-service, contract research organization focused on computer and structure-based ligand discovery. We typically work with biotech and small to mid-range pharma who do not have sufficient computational specialists on staff to undertake virtual screens and inhibitor design completely on their own. We do not retain any intellectual property in the projects that we undertake

Share this:              

Comments:

There are no comments yet. You can be the first.

Leave a Reply

Your email address will not be published. Required fields are marked *